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abstract
Objective: The purpose of this study was to evaluate the first implementation outside of Norway of the Bergen 
4-day treatment for Obsessive Compulsive Disorder (OCD), an innovative and effective treatment format with high 
acceptance and basically no drop-out. 
Method: Nineteen patients with OCD underwent the treatment at the Icelandic Anxiety Clinic (Kvíðameðferðarstöðin). 
Of these, 17 of the patients were classified pretreatment with severe to extreme symptoms and 2 were classified with 
moderate symptoms. 63% of the patients had previously received treatment for OCD (ERP or CBT). 
Results: Mean pretreatment score on Yale-Brown Obsessive Compulsive Scale (Y-BOCS) was 28.79 (SD = 4.42). 
One week post-treatment mean Y-BOCS score was 9.95 (SD = 3.67). 94.7% of the patients had responded to treatment 
and 73.7 were in remission according to the international consensus criteria. At 3-month follow-up, the Y-BOCS score 
was 11.09 (SD = 5.89) where 78.9% of the patients had responded to treatment and 63.2% were in remission. 
Conclusions: All patients expressed high satisfaction with the treatment format, and none of the patients would 
have preferred longer term treatment. The therapists also expressed satisfaction with the treatment format. The Bergen 
4-day treatment for OCD is a very promising treatment for OCD, and can be successfully implemented outside Norway. 
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Exposure and response prevention (ERP) along 
with cognitive behavioural therapy (CBT) are effective 
treatments for obsessive-compulsive disorder (OCD) 
(Fisher and Wells 2005, Öst et al. 2015, Skapinakis et 
al. 2016). Numerous variations in treatment formats 
have proven to be successful (Jónsson and Hougaard 
2009, Vogel et al. 2012) including more concentrated 
forms than weekly sessions (Abramowitz et al. 2003, 
Jónsson et al. 2015, Whiteside et al. 2008, Whiteside 
and Jacobsen 2010). Long term gains of those treatments 
have not been optimal however, with less than 50% of 
OCD patients obtaining long term recovery (Sunde et al. 
2017, Olajatuni et al. 2013, Öst et al. 2015).
A highly concentrated format of ERP has been 
developed in Bergen, Norway, where the treatment is 
delivered over four consecutive days in a group of 3-6 
patients with the same number of therapists, (the Bergen 
4-day treatment [B4DT]). For a detailed description of 
the approach, see Havnen et al. 2013, Havnen et al. 2017, 
hansen et al. in press. 
In an effectiveness study by Havnen et al. (2014) 
where 35 patients received this treatment format 77% 
were classified as recovered at post-treatment and 11% 
improved, applying the Jacobson and Truax (1991) 
criteria. The numbers were 74% and 14% respectively at a 
six-month follow-up. Over 90% of the patients expressed 
high contentment with the treatment format and content 
and only one patient dropped out of treatment. There 
was a significant improvement in depressive symptoms 
and positive changes in occupational interference, 
maintained at follow-up. This study was replicated in 
2017 where 42 patients underwent the same treatment 
format, delivered by different therapists than in Havnen 
et al. (2014), except for two groups led by the developers 
of the treatment format. At post-treatment, 74% of the 
patients were in remission and 60% had recovered at 
6-month follow-up (Havnen et al. 2017). Recently the 
results were replicated in a study with one year follow-
up. Among 65 patients that initiated the treatment, 83,1% 
responded to the treatment and 67,7% were classified as 
recovered at a 12-month follow-up (Hansen et al. 2018). 
It has also been shown that the results are maintained up 
to four years post-treatment with nearly 70% of patients 
classified as recovered (Hansen et al. 2019). 
By now more than 1300 patients in Norway have 
received the treatment format with good results, but it 
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psychotic or in active substance abuse, or do not speak 
Icelandic. Also, the treatment format is not initiated if 
patients are unwilling to refrain from use of anxiolytics 
during the 4 days of treatment. A total of 19 patients 
(53% female) between 17 and 40 years old were offered 
the treatment (Mage = 26.6, SDage = 7.4), they all accepted 
to participate and all completed treatment. The patients 
had to pay for the treatment as psychological treatment is 
not generally reimbursed in Iceland.
OCD duration, severity and previous treatments
Mean Y-BOCS score pretreatment was 28.79 (SD = 
4.42) with 17 patients (89.5%) classified with severe to 
extreme OCD (Y-BOCS from 24 to 40) and 2 patients 
(10.5%) with moderate OCD (Y-BOCS from 16 to 23). 
Mean duration of the OCD was 15,84 years (SD = 8,11) 
and 12 (63.2%) had previously received a psychological 
treatment, CBT or ERP. 62,2% of the patients were 
currently being treated with medication for their OCD 
symptoms. During the treatment patients were instructed 
not to make any changes in their medication. 
Comorbidity
68.4% of the patients had comorbid disorders 
where 36.8% had more than one. The most common 
was depression, as 52.6% of the patients had comorbid 
depression, 21% had generalized anxiety disorder, 
10.5% panic disorder without agoraphobia, 15.8% had 
social anxiety disorder, 5.2 % had an eating disorder and 
5.2% bipolar II. Patients with comorbid disorders did 
not differ from patients without comorbid disorders on 
pretreatment Y-BOCS scores (t (17) = 1.878, p = .078).
procedure
Referred patients met for an initial interview session 
for clinician administered MINI and the registration of 
anamnestic information, and when the OCD-diagnosis 
was established they met for two additional assessment 
sessions. The severity of obsessive–compulsive 
symptoms was assessed with the Yale-Brown Obsessive 
Compulsive Scale (Y-BOCS; Goodman et al. 1989a, 
1989b). The patients were then given an introduction 
to the 4-day treatment format, and also watched a video 
with Icelandic subtitles presenting the B4dt https://
youtu.be/_0iNr2G2VQA as well as a video presenting 
the outline and contents of the treatment format https://
www.youtube.com/watch?v=nqx8knpy3i4. The patients’ 
expectations of treatment outcome as well as their 
evaluation of treatment credibility were assessed with an 
adapted version of the Borkovec and Nau (1972) Reaction 
to Treatment Scale, in which four aspects of expectancy 
and credibility were evaluated on a 0–100% scale, with 
higher values indicating more positive evaluations. If 
a patient reported an expectancy or credibility score 
below 70%, this was taken as an opportunity to clarify 
possible misunderstandings regarding the treatment 
format. Patients were told that they would be asked to 
suggest exposure tasks on the first day of the treatment, 
and that it was recommended to choose exposures that 
the “OCD would dislike the most”. When admitted to 
a group, the patients watched another video explaining 
the treatment in more detail https://www.youtube.com/
watch?v=nqx8knpy3i4. The week ahead of the 4-day 
treatment, the group leader called each participant in 
order to ensure that they were ready to start treatment 
and that they had started to think of exposure tasks. 
remains to be seen whether this treatment format can be 
applied to other cultures. This study reports on its first 
implementation outside of Norway. Aims of the study 
were to replicate findings from Norway and assess the 
treatment format’s applicability to Iceland. The results 
will give insight into further application of the treatment 
format around the world. 
In order to ensure dissemination of the 4-day 
treatment format without reducing quality, procedures 
for training and certification of therapists as well as 
online registration of treatment results, have been 
established by developers of the treatment at Haukeland 
university hospital. since the B4dt is delivered in 
a group setting where the ratio between patients and 
therapists is 1:1, this serves as an ideal setting for giving 
hands-on training to new 4-day therapists. the trainees 
can observe and learn from experts, and the experts 
can give feedback to the trainees after having observed 
them in the actual clinical setting. In order to become 
a qualified 4-day therapist, it is required that the trainee 
first participate in one 4-day group to get acquainted with 
the format, followed by a minimum of two participations 
in 4-days groups where an expert evaluates the trainee on 
specified core competencies (Kvale et al. manuscript in 
preparation). In order to qualify as a 4-day group leader, 
participation in six groups is required combined with an 
evaluation of core competencies for group leaders. The 
first two groups in Iceland were thus led by an Icelandic 
speaking Norwegian therapist experienced in delivering 
the treatment format. 
although Icelandic and norwegian cultures are 
related, it was by no means obvious that B4DT would 
work in Iceland. Indeed, when the Icelandic therapists 
observed the B4DT for the first time in Norway, 
they commented that parts of the psychoeducation, 
metaphors and the way therapists and patients work in 
the group, might seem strange in Iceland. Despite this 
it was decided to make a translation without adaptation. 
The Icelandic Anxiety Clinic (Kvíðameðferðarstöðin) 
was also a suitable location for the treatment format in 
Iceland, being an outpatient clinic with an OCD-team 
of six psychologists trained in CBT and ERP. Up to the 
implementation of the 4-day treatment format at the 
Icelandic Anxiety Clinic, OCD-patients were provided 
with CBT or ERP weekly or biweekly. The team found 
it challenging to treat patients with severe ocd on a 
weekly basis due to risk of relapse between sessions and 
premature termination of treatment. The Bergen 4-day 
treatment format seemed appealing with practically 
no dropout and rapid and long lasting results. It could 
substantially speed up recovery and suit people in rural 
areas that have difficulties attending weekly sessions in 
the city. There is also good experience with intensive 
therapy at the Icelandic Anxiety Clinic where specific 
phobia has been treated for years with one session 
Treatment (Thompson et al. 2012).
method
Participants
This study is a part of a standard quality control at an 
outpatient clinic in Iceland, the Icelandic Anxiety Clinic 
(Kvíðameðferðarstöðin). Patients either contact the clinic 
directly or are referred by other professionals. patients 
with suspected OCD are referred to the OCD-team at the 
clinic where treatment is offered if a principal diagnosis of 
ocd on mini International neuropsychiatric Interview 
(MINI; Sheehan et al. 1998) is confirmed. The 4-day 
treatment format is not initiated if patients are suicidal, 
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containing 9 questions each ranging from 0 to 3, yielding 
a maximum score of 27. According to Kroenke et al. 
(2010), a score of 10 or more is indicative of a depressive 
disorder. The psychometric properties of PHQ-9 are 
well-established (Titov et al. 2011, Feng et al. 2016). 
The 7 item Generalized Anxiety Disorder Scale 
(GAD-7; Spitzer et al. 2006) measures symptoms of 
generalized anxiety. The psychometric properties are 
well-established (Beard and Björgvinsson 2014, Hinz et 
al. 2017, Kroenke et al. 2010, Rutter and Brown 2017). 
therapists
The first two groups of the individualized group 
treatment were led by an Icelandic speaking Norwegian 
psychologist, with extensive experience delivering the 
4-day format. The third group was led by a psychologist 
at the Icelandic Anxiety Clinic that has more than 15 
years of experience in delivering cognitive behavioural 
therapy and is a member of the OCD-team. The co-
therapists all had extensive training and practice in 
cognitive behavioural therapy of anxiety disorders 
and are part of the OCD-team. The developers of the 
treatment format attended the groups to ensure that the 
treatment was correctly implemented. 
statistical analyses
Statistical analyses were performed with SPSS 
version 24.0. Repeated measures ANOVA for Y-BOCS, 
GAD-7 and PHQ-9 were conducted with Greenhouse-
Geisser corrections. Effect sizes were calculated with 
Cohen’s d, defined as (Mpre-Mpost)/SDpre as recommended 
by Morris and DeShon (2002). There were no missing 
data for Y-BOCS, PHQ or GAD-7 pre-treatment. All 
patients were available for y-Bocs evaluation post-
treatment and 18 of 19 at 3-month follow-up. When less 
than 25% of a data set is missing and the data is missing 
at random, which was the case for this data set, the 
expectation maximization algorithm can be an efficient 
method of replacing data, as it requires no simulation 
of data sets (Schafer 1997). For imputing the missing 
3-month Y-BOCS data (<5%), all covariates and outcome 
variables at each time point were included to impute 
missing data points, as suggested by Schafer (1997).
results
OCD symptoms
Means, standard deviations and effect sizes for change 
in Y-BOCS score pre- and post and pre- and 3-month 
follow-up are presented in table 1 and in figure 1. We ex-
amined Y-BOCS scores using repeated measures ANOVA 
with greenhouse-geisser correction. the results showed 
a significant change on Y-BOCS (F(1.57, 28.26) = 86.48, 
p < .0001), η2 = 0.887. There was a significant reduction 
in Y-BOCS from pre- (M = 28.79, SD = 4.42) to post-
treatment (M = 9.95, SD = 3.67), of 18.84 points (95% CI, 
15.51 to 22.17), p <0. 001). The increase in Y-BOCS from 
post-treatment to 3-month (M = 11.09, SD = 5.89), of 1.14 
(95% CI, -1.39 to 3.67), was not significant p = 0.356.
The first day in the group setting is allocated to 
a manualized psychoeducation and planning of the 
exposures. Day two and three, the patients do individually 
tailored and therapist assisted exposure training in as 
many OCD-relevant settings as possible, with continued 
self-administered training in the evening. During the 
exposures, the patients are taught to pay attention to all 
the temptations to practice subtle avoidance and to use 
these as opportunities to actively do something that is 
incompatible with practicing OCD.
Day two and three, the group meets in the morning, 
at lunch and in the afternoon to share the progress and 
challenges with the exposure training. In the afternoon 
the third day, relatives and significant others are invited 
to a psychoeducation focused on understanding ocd 
and on how they best might support the patient in their 
efforts to get rid of the ocd. on the fourth day patients 
are taught strategies for maintaining change and further 
self-administered training tasks for the next three weeks 
are planned. during this period, the patients record 
online the way they work and their progress without 
therapist contact. Three months post-treatment, patients 
are invited for a booster session without any exposures.
Assessment
Prior to the first assessment session, patients were 
sent a number of self-report questionnaires (see below) 
to be completed before the first visit at the clinic. These 
questionnaires were also completed at the end of the 
treatment, as well as at three months after treatment. All 
patients were informed that data were routinely collected 
as part of standard quality control procedures at the clinic. 
the mInI interviews were conducted by psychologists 
trained in the administration of this structured clinical 
interview. 
The Y-BOCS interviews at pre-treatment were 
conducted by one of the psychologists in the OCD-team. 
Y-BOCS at post-treatment as well as at 3-month follow-
up were conducted by phone by an independent assessor. 
the independent assessor was aware that the patients 
had received concentrated ERP treatment, but was 
otherwise not involved in the study. y-Bocs interviews 
were conducted by clinicians with special training in 
performing the interview. 
materials
The Y-BOCS interview consists of 10 items designed 
to rate the severity and type of symptoms of patients 
with obsessive compulsive disorder (OCD). It has good 
psychometric properties (Goodman et al. 1989a, 1989b). 
Client Satisfaction Questionnaire 8 (CSQ-8; Larsen 
et al. 1979, Nguyen et al. 1983) is an 8-item questionnaire 
which measures patient satisfaction with health services. 
Each item is scored from 1 (very low satisfaction) to 4 
(very high satisfaction), total score ranges from 8 to 32 
with higher scores indicating higher degree of satisfaction. 
The CSQ-8 has sound psychometric properties (Larsen 
et al. 1979, Nguyen et al. 1983). 
Patient Health Questionnaire-9 (PHQ-9; Kroenke 
et al. 2010) is a self-administered screening instrument 
Table 1. Means and standard deviations on Y-BOCS
Y-BOCS M SD d
Pre-treatment 28.79 4.42
Post-treatment 9.95 3.67 4.26
3-month follow-up 11.09 5.89 4.01
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measures ANOVA showed a signifi cant decrease in 
symptoms of generalized anxiety, F(1,18) = 24.826, p < 
0.001, η2 = 0.580. Repeated measures ANOVA showed 
also a signifi cant decrease in symptoms of depression, 
F(1,18) = 17.336, p < 0.001, η2 = 0.491. 
Figure 1. Change in OCD symptom severity
Depression and generalized anxiety
Means, standard deviations and effect sizes for 
change in depressive symptoms and generalized anxiety 
from pre- to 1 week post-treatment are shown in table 
2 and the changes over time in fi gure 2. repeated 




Post-treatment 7.47 4.50 0.94
GAD 7
Pre-treatment 12.58 4.35 1.26
Post-treatment 7.11 3.93
Figure 2. Depression and generalized anxiety symptom severity during and after treatment
Bergen 4-day treatment for OCD in Iceland
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Treatment response
the international consensus criteria was applied to 
determine the percentage of patients that showed clinical 
improvement (Mataix-Cols et al. 2016). The criteria 
requires a 35% reduction of the pre-treatment Y-BOCS 
score in order to be classified as a clinically relevant 
response, and remitted if the post-treatment Y-BOCS 
score is 12 points or lower. 1 week post-treatment 94.7 
% had responded and 73.7% were in remission. At 
3-month follow-up 78.9% had responded and 63.2% 
were in remission. 
Comparison with results from Norway
Comparison between treatment response in patients 
in Iceland and norway can be seen in table 3. the 
severity of OCD symptoms was greater in the Icelandic 
patients pretreatment. Post-treatment and 3 months after 
treatment there is no difference between the symptom 
severity in patients in norway and Iceland. 
discussion
The aim of the study was to assess the applicability 
of the Bergen 4-day treatment format (B4DT) for OCD 
in Iceland. The results show that the implementation 
was highly successful. all patients who were offered 
the treatment format accepted and none of the patients 
dropped out during treatment. The patients showed great 
improvements in both OCD symptom severity as well 
as symptoms of depression and generalized anxiety 
and these results were maintained at 3-month follow-
up where 78.9% had responded and 63.2% were in 
remission. Patients expressed high satisfaction with the 
treatment format, and none of the patients would have 
preferred longer term treatment. The therapists also 
expressed satisfaction with the treatment format. 
The results are comparable to prior studies on the 
treatment format (Havnen et al. 2017, Hansen et al. 
2018). Furthermore, this treatment format may be 
effective with patients with previous unsuccessful 
treatments for OCD as the majority of the patients in 
the study had prior ERP or CBT treatment. The high 
recovery rate among those suffering from severe OCD 
is promising, as it might be suspected that this form 
of treatment would be too demanding for them. The 
treatment format thus seems to work well for patients in 
Iceland that are severely affected by ocd. 
one of the strengths of this study is that it is 
naturalistic, that is part of ordinary health care, with 
high generalizability. It is however important to note 
that the Icelandic patients have to pay for this treatment, 
Table 3. Comparison between treatment response in Iceland and in Norway (Havnen et al. 2014)
Y-BOCS Bergen 4 day in Iceland Bergen 4 day in Norway p
N M(SD) N M(SD)
Pre 19 28.79 (4.42) 34 26.06 (4.37) p =0.03*
Post 19 9.95 (3.67) 34 9.00 (4.84) p=0.46
3 month 19 11.09(5.89) 34 10.71 (7.09) p=0.84
Note. * = significant at 0.05 level.
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